Get my own profile
Public access
View all6 articles
0 articles
available
not available
Based on funding mandates
Co-authors
- Joshua E AllenOncoceuticsVerified email at oncoceutics.com
- Wafik El-DeiryAssociate Dean, Warren Alpert Medical School, Brown UniversityVerified email at brown.edu
- Stephan A. GruppProfessor of Pediatrics, University of Pennsylvania School of MedicineVerified email at chop.edu
- Varun Vijay PrabhuSenior Director R&D, ChimerixVerified email at chimerix.com
- Carl JuneUniversity of PennsylvaniaVerified email at upenn.edu
- Bruce L LevineBarbara and Edward Netter Professor in Cancer Gene Therapy, Department of Pathology and LaboratoryVerified email at pennmedicine.upenn.edu
- Amriti R. LullaMD Anderson Cancer CenterVerified email at mdanderson.org
- BORA LIMThe University of Texas MD Anderson Cancer CenterVerified email at mdanderson.org
- Pamela A. ShawKaiser Permanente Washington Health Research InstituteVerified email at kp.org
- Niklas FinnbergProPharma Group SwedenVerified email at propharmagroup.com
- Alix SeifChildren's Hospital of PhiladelphiaVerified email at email.chop.edu
- Rohinton TaraporePostdoctoral researcherVerified email at mail.med.upenn.edu
- Gerald WertheimChildren's Hospital of PhildelphiaVerified email at email.chop.edu
- Emmanuel Kwame Teye MS PhDThe Pennsylvania State University College of MedicineVerified email at alumni.psu.edu
Follow
MALA TALEKAR
VP Clinical Development, Verismo Therapeutics; Attending Physician, CHOP
Verified email at verismotherapeutics.com